Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer

Bibliographic Details
Title: Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer
Authors: Maria Frantzi, Marie C. Hupe, Axel S. Merseburger, Joost P. Schanstra, Harald Mischak, Agnieszka Latosinska
Source: Diagnostics, Vol 10, Iss 9, p 658 (2020)
Publisher Information: MDPI AG, 2020.
Publication Year: 2020
Collection: LCC:Medicine (General)
Subject Terms: biomarkers, drug targets, omics, prostate cancer, Medicine (General), R5-920
More Details: Prostate cancer (PCa) is one of the most frequently diagnosed malignancies, and the fifth leading cause of cancer related mortality in men. For advanced PCa, radical prostatectomy, radiotherapy, and/or long-term androgen deprivation therapy are the recommended treatment options. However, subsequent progression to metastatic disease after initial therapy results in low 5-year survival rates (29%). Omics technologies enable the acquisition of high-resolution large datasets that can provide insights into molecular mechanisms underlying PCa pathology. For the purpose of this article, a systematic literature search was conducted through the Web of Science Database to critically evaluate recent omics-driven studies that were performed towards: (a) Biomarker development and (b) characterization of novel molecular-based therapeutic targets. The results indicate that multiple omics-based biomarkers with prognostic and predictive value have been validated in the context of PCa, with several of those being also available for commercial use. At the same time, omics-driven potential drug targets have been investigated in pre-clinical settings and even in clinical trials, holding the promise for improved clinical management of advanced PCa, as part of personalized medicine pipelines.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2075-4418
Relation: https://www.mdpi.com/2075-4418/10/9/658; https://doaj.org/toc/2075-4418
DOI: 10.3390/diagnostics10090658
Access URL: https://doaj.org/article/38b42fa88b1d4b7e9e3b7a9692d992b5
Accession Number: edsdoj.38b42fa88b1d4b7e9e3b7a9692d992b5
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20754418
DOI:10.3390/diagnostics10090658
Published in:Diagnostics
Language:English